---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-22-001082"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2022-09-09T23:59:59+00:00"
generated_at: "2026-06-23T11:48:10.002752+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# IGC shareholders elect directors, ratify auditor, approve 3M share grant

## Summary
- Ram Mukunda, James Moran elected Class C directors until 2025; Claudia Grimaldi elected Class A director until 2023.
- Ratified Manohar Chowdhry & Associates as independent auditor for fiscal 2023.
- Approved grant of 3,000,000 common shares to employees, advisors, directors under performance/vesting metrics.
- Total shares voted: 35,103,116 (67.40% of outstanding); broker non-votes 11,861,428.

## SEC filing metadata
- accession: 0001185185-22-001082
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2022-09-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 5.07, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/0001185185-22-001082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/indiaglob20220909_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-22-001082
- JSON: https://secwatch.observer/filing/0001185185-22-001082.json
- Plain text: https://secwatch.observer/filing/0001185185-22-001082.txt

## Key facts
- Executive change
  Ram Mukunda was elected as Class C Director at IGC Pharma, Inc..
  - Action: elected
  - Role: Class C Director
  source text: On September 9, 2022, Ram Mukunda and Congressman James Moran were elected to India Globalization Capital’s (the “Company”) Board of Directors at the 2022 Annual Meeting of Stockholders (the “Annual Meeting”), to serve as Class C directors, until the 2025 annual meeting of stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/0001185185-22-001082-index.htm
- Executive change
  Claudia Grimaldi was elected as Class A Director at IGC Pharma, Inc..
  - Action: elected
  - Role: Class A Director
  source text: and Ms. Claudia Grimaldi was elected to the Company’s Board of Directors at the Annual Meeting, to serve as a Class A director, until the 2023 annual meeting of stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/0001185185-22-001082-index.htm
- Executive change
  James Moran was elected as Class C Director at IGC Pharma, Inc..
  - Action: elected
  - Role: Class C Director
  source text: On September 9, 2022, Ram Mukunda and Congressman James Moran were elected to India Globalization Capital’s (the “Company”) Board of Directors at the 2022 Annual Meeting of Stockholders (the “Annual Meeting”), to serve as Class C directors, until the 2025 annual meeting of stockholders
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001082/0001185185-22-001082-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.